Xi Venture Capital Helps Yisheng Micro Nano Build an Advanced Ultrasonic Core Technology Research and Development Platform

　　Today, Wuxi Yisheng Weina Medical Technology Co., Ltd. (hereinafter referred to as "Yisheng Weina") announced the successful completion of tens of millions of yuan in Series A financing. Several well-known investment institutions, including Xi Venture Capital and Qiao Jing Capital, participated in this round of financing. The funds raised in this round will mainly be used for rapid expansion of the R&D team, continuous promotion of the R&D progress of Yisheng Micro Nano products, acceleration of production base operation and commercial construction, realization of mass production of multiple products, continuous improvement of delivery capabilities, and meeting the rapidly growing needs of industry customers.

　　The core members of the Yisheng Micro Nano team come from China University of Science and Technology, Harbin Institute of Technology, Tongji University, Nanjing University, Zhejiang University, and have work experience in well-known medical device companies such as GE and Philips. The company has collaborated with several well-known universities in China to strengthen industry university research cooperation and technical exchanges, providing a guarantee for continuous technological innovation. The company is in the ultrasound imaging series (10F miniature interventional imaging probe, 8F miniature interventional imaging probe, extracorporeal conventional imaging probe); The ultrasound therapy series (ultrasound ablation, ultrasound knife transducer) and ultrasound beauty rehabilitation series have mature solutions.